Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Clinical Associate Professor, Group leader

Member of:

    ORCID: 0000-0002-4239-4939

    Publication year:
    All
    1 - 3 out of 3Page size: 10
    1. 2003

    2. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

      Rasmussen, T., Theilgaard-Mønch, Kim, Hudlebusch, H. R., Lodahl, M., Johnsen, H. E. & Dahl, I. M. S., 2003, In: British Journal of Haematology. 123, 2, p. 253-62 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.

      Theilgaard-Mønch, Kim, Raaschou-Jensen, K., Schjødt, K., Heilmann, C., Vindeløv, L., Jacobsen, N. & Dickmeiss, E., 2003, In: Bone Marrow Transplantation. 32, 12, p. 1125-33 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors.

      Sørensen, O. E., Cowland, J. B., Theilgaard-Mønch, Kim, Liu, L., Ganz, T. & Borregaard, N., 2003, In: Journal of Immunology. 170, 11, p. 5583-9 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3997971